Home Categories API Levofloxacin
A5309812

Levofloxacin , >98.0%(HPLC) , 100986-85-4

Synonym(s):
(−)-Ofloxacin;Levofloxacin hemihydrate

CAS NO.:100986-85-4

Empirical Formula: C18H20FN3O4

Molecular Weight: 361.37

MDL number: MFCD03265511

EINECS: 600-146-0

Pack Size Price Stock Quantity
5G RMB48.80 In Stock
25G RMB104.00 In Stock
100G RMB346.40 In Stock
500g RMB1285.60 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 218°C
Boiling point: 572℃
Density  1.48±0.1 g/cm3(Predicted)
Flash point: >110°(230°F)
storage temp.  Keep in dark place,Sealed in dry,2-8°C
solubility  chloroform: soluble10mg/mL
form  powder
pka 5.19±0.40(Predicted)
color  white to faint yellow
optical activity [α]20/D -104±4° in chloroform
Water Solubility  Slightly soluble in water or methanol. Soluble in glacial acetic acid or dichloromethane
Sensitive  Light Sensitive
Merck  14,6771
BRN  7327015
BCS Class 3,1
InChIKey GSDSWSVVBLHKDQ-JTQLQIEISA-N

Description and Uses

Levofloxacin, the optically active S-isomer of the fluoroquinolone antibiotic ofloxacin, is two to four times more potent than ofloxacin with reportedly less side effects in treating infections of the lower respiratory and urinary tract, prostate infections and sexually transmitted diseases. It has broad and potent antibacterial activity over common Grampositive and -negative aerobic pathogens and obligate anaerobes. Different from the cephem antibiotics, levofloxacin is unique in its marked selectivity against members of the family Enterobacteriaceae and its negligible effect on predominant anaerobes. Levofloxacin also exhibits satisfactory antimicrobial effects in surgical infections and it may be used for treatment of gastrointestinal infections such as traveler’s diarrhea associated with the pathogenic Enterobacteriaceae.

Levofloxacin is a broad-spectrum antibiotic used in pharmacokinetic?, antibiotic resistance?, and resistance prevention?studies. Levofloxacin is active against Gram-positive and Gram-negative bacteria. It inhibits DNA gyrase (type II topoisomerase) and topoisomerase IV, thereby inhibiting cell division.

Safety

Symbol(GHS) 
GHS07,GHS08
Signal word  Danger
Hazard statements  H302-H317-H334
Precautionary statements  P261-P264-P270-P280-P301+P312-P302+P352
Hazard Codes  Xn
Risk Statements  22-42/43-68-20/21/22-64-63
Safety Statements  26-36/37/39-36
RIDADR  UN 1648 3 / PGII
WGK Germany  3
RTECS  UU8815550
HS Code  29349990
Toxicity LD50 oral in rat: 1478mg/kg

RELATED PRODUCTS